MedTrace Logo

A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality

NCT05839964 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 301

Last updated 2023-05-03

No results posted yet for this study

Summary

This is a randomized, double-blind, placebo-controlled, study to assess the safety and effects of CHI-560, CHI-563, CHI-564, \& CHI-565 versus placebo on sleep quality in healthy adult participants ages 18-55 years.

Conditions

  • Healthy Adults

Interventions

DIETARY_SUPPLEMENT

CBN and CBD

CBN and CBD in Gummy Format

Sponsors & Collaborators

  • Canopy Growth Corporation

    lead INDUSTRY

Principal Investigators

  • Matthew T Feldner, PhD · Canopy Growth Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-16
Primary Completion
2022-12-06
Completion
2022-12-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05839964 on ClinicalTrials.gov